Prescription Pattern of Anti-Plateletic Drugs, Clinical Manifestations and Risk Factors in Cerebro Vascular Accident: A Prospective Observational Study
Main Article Content
Abstract
Aim: The aim and objective of the study is to evaluate the prescription pattern of anti-plateletic agents used in the treatment of stroke and clinical symptoms and risk factors, among hospitalized stroke patients.
Materials and Method: A six-month prospective observational study that was carried out in the neurology department. A standard procedure was followed for the documentation and analysis of all the data. A total of 120 patients selected for the study who satisfying the inclusion and exclusion criteria.
Results: Out of total 120 patients, the most prevalent type of stroke was found to be ischemic stroke of 92%. Females were found mostly to be diagnosed by stroke. Aspirin (65%) was found to be the most common anti-plateletic agent used in the treatment of stroke followed by clopidogrel and its combination. Majority of patients experienced slurred speech (37.5%), followed by weakness as the clinical presentation of stroke. Hypertension (49.1%) was found to be the most prevalent risk factor of stroke followed by diabetes mellitus.
Conclusion: The study provides a concise summary of the clinical symptoms, risk factors, and prescription pattern of anti-platelet therapy in stroke patients. By proper identification and rectification of the strong contributable risk factor for stroke may lead to a good prognosis of treatment of stroke.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. National Collaborating Centre for Chronic Conditions (UK). Stroke: National Clinical Guideline for Diagnosis and Initial Management of Acute Stroke and Transient Ischaemic Attack (TIA). London: Royal College of Physicians (UK); 2008. (NICE Clinical Guidelines, No. 68 (1), Introduction. Available from: https://www.ncbi.nlm.nih.gov/books/NBK53302/
II. Dipiro J T, Talbert R L, Yee G C, Matzke G R, Wells B G, Posey l M.Sroke. Pharmacotherapy A pathophysiologic Approach.8th ed.2011:353-362
III. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, et al. Heart disease and stroke Statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133(4):e38–360.
IV. Kamalakannan S, Gudlavallet V S M, Gudlavalleti A S V, Goenka S, Kuper H. Incidence and Prevalance of stroke in India: A Systematic review. National Library of medicine.2017 August; 146(2):175-185
V. Boehme AK, Esenwa C, Elkind MSV. Stroke risk factors, genetics, and prevention. Circ Res. 2017;120(3):472–95.
VI. Raltson S H, Penman I D, Hobson R P, Strachan M WJ.Stroke medicine. Davidsons principles and Practice of medicine,23rd edition.2018:1151-1162
VII. Powers WJ,, Rabinstein AA,, Ackerson T,, Adeoye OM, Bambakidis NC,, Becker K,, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018;;49::e46.. 2018.
VIII. Hussainy SA, Habeeb M, Jeelani A, Sultana S et al., A prospective observational study on risk factors and prescribing pattern of drugs used in stroke patients at a tertiary care teaching hospital; Sep-Oct 2020, volume (10):NO 5-S (supplement issue).
IX. Reeves MJ, Bushnell CD et al., Sex differences in stroke- Epidemiology, clinical presentation, medical care and outcomes. Lancet Neurology; Oct 2008, volume (7), issue (10): 915-926.
X. Punna S, Shailendra D, Mohammad A B, Balla K S, Joseph A K, Edem S, et al. Clinical profile of patients with stroke in a tertiary care hospital setting in rural telangana. National Journal of physiology, Phamacy and practice.2020;10(6):473-477.
XI. Naqvi IA, Kamal AK, Rehman H. Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack. Cochrane Database Syst Rev. 2020;8(8):CD009716.
doi: 10.1002/14651858.CD009716.pub2.
XII. Vurumadla S, Rakshith V et al., A study on symptoms, risk factors and prescribing pattern of drugs used in stroke patients. International journal of pharmacy and pharmaceutical sciences; Nov 2015, volume (7), issue (1): 421-426.
XIII. Fekadu G, Chelkeba L, Kebede A. Riskfactor, clinical presentation and predictors of stroke among adult patients admitted to stroke unit of Jimma university medical center, south west Ethiopia: A prospective observational Study. BMC Neuroogy.2019;19:187.